Logo-ps

 

Follower of ICMJE

Powered by:
Pharm Sci. 2021;27(3): 439-449. doi: 10.34172/PS.2020.93

Research Article

Risk Factors of Supply Chain in Biopharmaceutical Companies in Iran

Hadi Abbasian 1, Reza Yousefi-Zenouz 2, Akbar Abdollahiasl 1, Mahdi Toroski 1, Shekoufeh Nikfar 1, Mohammadreza Siahi-Shadbad 3, Abbas Kebriaeezadeh 1 * ORCID

Cited by CrossRef: 3

1- Daoud-BenAmor W, García-Zamora D, Frikha H, López L. Assessment of pharmaceutical supply risk during COVID-19 crisis: A novel MCGDM approach based on minimum cost consensus models. Computers & Industrial Engineering. 2026;213:111790 [Crossref]
2- Baghban K, Parashkouhi S, Abbasian H, Varmaghani M, Noroozi M. Access to pediatric oncology medicine in Iran: a cross-sectional survey in Urmia. BMC Pediatr. 2025;25(1) [Crossref]
3- Safardoust A, Ghanei M, Mahboudi F, Pourqasem M, Mirmohammadi S, Moghadasian M. The current status, trends, and developments in biopharmaceutical policy making in Iran. JSTPM. 2025; [Crossref]
4- D, T. Updated Review on Risk Management Strategies in Quality Assurance for the Pharmaceutical Industry. Int J of Allied Med Sci and Clin Res. 2025;13(2):343 [Crossref]
5- Abbasian H, Yousefi-Zenouz R, Amirkhani A, Shirzadeh M, Abdollahiasl A, Nikfar S, Siahi-Shadabad M, Kebriaeezadeh A, Natella R. Risk Assessment for Complex Systems Based on Fuzzy Cognitive Maps: A Case of the Biopharmaceutical Industry. Complexity. 2024;2024(1) [Crossref]
6- Astuti R, Rizkyastama F, Dania W, Rahayu L. Risk Mitigation Priorities in a Sustainable Pasteurized Milk Supply Chain: A House of Risk Approach in a Small-Scale Dairy Company. BIO Web Conf. 2026;208:05006 [Crossref]

   Indexing & Abstracting: